MedTrace Logo

PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare

NCT07209722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1377

Last updated 2026-01-26

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.

Conditions

  • PrEP Precriptions for Reproductive Aged Women

Interventions

BEHAVIORAL

PrEP acronym (pre-exposure prophylaxis)

Tracked PrEP prescriptions over 8 months among patients who completed the survey

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Michael Mugavero, MD · University of Alabama at Birmingham

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-22
Primary Completion
2025-08-16
Completion
2025-08-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07209722 on ClinicalTrials.gov